insights_auto
Outlook: 70.0% bullish·0.0% bearish
Go to analysischevron_right
H1UM34:BVMF
Humana Inc Bdr
R$48.16
0.00%
(0.00) 1D
Oct 9, 4:56:00 PM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for H1UM34...
Open
R$48.04
High
R$50.27
Low
R$47.80
Mkt. cap
51.86B
Avg. vol.
176.00
Volume
678.00
52-wk high
R$50.27
52-wk low
R$19.00
Shares outstanding
120.08M
No. of employees
67K
Open
R$48.04
High
R$50.27
Low
R$47.80
Mkt. cap
51.86B
Avg. vol.
176.00
Volume
678.00
52-wk high
R$50.27
52-wk low
R$19.00
Shares outstanding
120.08M
No. of employees
67K
News stories
From web sources and news partners
Yahoo Finance
·
12 hours ago
Humana (HUM) Stock Trades Up, Here Is Why
Timothy Sykes
·
15 hours ago
HUM Stock Soars As Medicare Advantage Ratings Spark Analyst Upgrades
The Motley Fool
·
17 hours ago
Stock Market Midday, Oct. 9: Stocks Edge Higher, Humana jumps 13%
CNBC
·
19 hours ago
Humana surges after topping 2027 Medicare star ratings
Profile
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S. Wikipedia
About Humana Inc Bdr
CEOJim Rechtin
Employees67.1K
Founded1961
HeadquartersLouisville, Kentucky, United States
SectorHealth care provider
Websitehumana.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 32.65B | 32.52B | 39.65B | 40.87B |
Cost of goods sold | 27.99B | 28.72B | 33.71B | 35.37B |
Cost of revenue | 27.99B | 28.72B | 33.71B | 35.37B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 3.82B | 4.21B | 3.93B | 3.92B |
Operating expense | 3.99B | 4.38B | 4.09B | 4.08B |
Total operating expenses | 31.98B | 33.10B | 37.80B | 39.45B |
Operating income | 667.00M | -583.00M | 1.85B | 1.42B |
Other non operating income | -35.00M | -53.00M | 34.00M | -211.00M |
EBT including unusual items | 108.00M | -1.02B | 1.58B | 931.00M |
EBT excluding unusual items | 438.00M | -796.00M | 1.68B | 987.00M |
Income tax expense | -86.00M | -249.00M | 395.00M | 238.00M |
Effective tax rate | -79.63% | 24.29% | 25.02% | 25.56% |
Other operating expenses | - | - | - | - |
Net income | 195.00M | -796.00M | 1.19B | 694.00M |
Net profit margin | 0.60% | -2.45% | 2.99% | 1.70% |
Earnings per share | 3.24 | -3.96 | 10.31 | 7.61 |
Interest and investment income | - | - | - | - |
Interest expense | -168.00M | -146.00M | -193.00M | -197.00M |
Net interest expenses | -168.00M | -146.00M | -193.00M | -197.00M |
Depreciation and amortization charges | 173.00M | 164.00M | 163.00M | 159.00M |
EBITDA | 871.00M | -389.00M | 2.05B | 1.60B |
Gain or loss from assets sale | 63.00M | 4.00M | - | - |